FDA Drug Application (021268) for TEVETEN HCT by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021268
Product Number001
FormTABLET;ORAL
Dosage600MG;12.5MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTEVETEN HCT
Active IngredientEPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE

Active IngredientCount
List of drugs with Active Ingredient EPROSARTAN MESYLATE3
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122


Back to FDA Applications sponsored by ABBVIE